These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9361631)

  • 1. Methadone maintenance: BC leads the way.
    Anderson JF
    CMAJ; 1997 Nov; 157(9):1198. PubMed ID: 9361631
    [No Abstract]   [Full Text] [Related]  

  • 2. [Methadone as a substitution treatment].
    Paris P
    Rev Infirm; 1995 Oct; (15):55-60. PubMed ID: 8920441
    [No Abstract]   [Full Text] [Related]  

  • 3. Physicians practicing in methadone treatment programs: who are they and what do they do?
    Wechsberg WM; Flannery B; Kasten JJ; Suerken C; Dunlap L; Roussel AE; Crum L; Murdoch O; Diesenhaus H
    J Addict Dis; 2004; 23(2):15-31. PubMed ID: 15132340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The outcome of the patient treated with methadone].
    Remy C
    Rev Med Brux; 1997 Sep; 18(4):312-6. PubMed ID: 9411666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heroin substitutes. Daily dose].
    Lagier G
    Servir; 1996; 44(5):260-2. PubMed ID: 9001088
    [No Abstract]   [Full Text] [Related]  

  • 6. Methadone maintenance treatment: a Canadian perspective.
    Brands B; Marsh DC
    CMAJ; 1997 Aug; 157(4):399-401. PubMed ID: 9275949
    [No Abstract]   [Full Text] [Related]  

  • 7. [Maternal lactation in mothers undergoing treatment with methadone substitution].
    Lemire L
    Soins Pediatr Pueric; 2006; (231):27-9. PubMed ID: 17017645
    [No Abstract]   [Full Text] [Related]  

  • 8. Methadone treatment: common questions, a common answer.
    Newman RG
    Ann Med Interne (Paris); 2001 Nov; 152 Suppl 7():4-5. PubMed ID: 11965091
    [No Abstract]   [Full Text] [Related]  

  • 9. Methadone, morphine and PTSD.
    Macleod AD; Duffy SG
    Aust N Z J Psychiatry; 2002 Dec; 36(6):816-7. PubMed ID: 12406127
    [No Abstract]   [Full Text] [Related]  

  • 10. Abstinence-based incentives in methadone maintenance: interaction with intake stimulant test results.
    Stitzer ML; Peirce J; Petry NM; Kirby K; Roll J; Krasnansky J; Cohen A; Blaine J; Vandrey R; Kolodner K; Li R
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):344-50. PubMed ID: 17696681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone treatment in general practice.
    Byrne A
    Aust Fam Physician; 1994 Sep; 23(9):1806-7. PubMed ID: 7980185
    [No Abstract]   [Full Text] [Related]  

  • 12. Methadone and the private practitioner.
    Freymuth HW
    J Med Soc N J; 1970 Mar; 67(3):128-30. PubMed ID: 5264627
    [No Abstract]   [Full Text] [Related]  

  • 13. Approach for treating methadone patients created.
    Hosp Peer Rev; 2008 Jul; 33(7):98-100. PubMed ID: 19035035
    [No Abstract]   [Full Text] [Related]  

  • 14. Pain management in the chemically dependent patient.
    Hicks RD
    Hawaii Med J; 1989 Nov; 48(11):491-2, 494-5. PubMed ID: 2574167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone replacement therapy.
    Brownlie JM
    N Z Med J; 1972 May; 75(480):312-3. PubMed ID: 4503628
    [No Abstract]   [Full Text] [Related]  

  • 17. Retention and illicit drug use among methadone patients in Israel: a gender comparison.
    Schiff M; Levit S; Moreno RC
    Addict Behav; 2007 Oct; 32(10):2108-19. PubMed ID: 17335982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The practitioner and reduction of risks].
    Leckie M
    Rev Med Suisse Romande; 1998 Sep; 118(9):739-42. PubMed ID: 9810183
    [No Abstract]   [Full Text] [Related]  

  • 19. Proportional hazards frailty models for recurrent methadone maintenance treatment.
    Nosyk B; MacNab YC; Sun H; Fischer B; Marsh DC; Schechter MT; Anis AH
    Am J Epidemiol; 2009 Sep; 170(6):783-92. PubMed ID: 19671835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone treatment in British Columbia: bad medicine?
    Graham D
    CMAJ; 1987 Mar; 136(6):564-6. PubMed ID: 3815220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.